Literature DB >> 10208651

Pitfalls in N-acetyltransferase 2 genotyping.

I Cascorbi1, I Roots.   

Abstract

In recent times, an increasing number of different haplotypes of the arylamine N-acetyltransferase 2 gene are reported. Since most of the various alleles are defined by linkages of commonly known hereditary point mutations, some confusion may occur when the mutation pattern revealed by genotyping should be addressed correctly to defined haplotypes. Moreover, problems take place when different nomenclatures are incorrectly transferred. To meet growing concerns regarding exact NAT2 genotyping and correct nomenclature, we summarized typical pitfalls in methodologies and terminologies. NAT2 genotypes containing rare alleles, or even combinations of them, should always be checked critically for possible laboratory failures. Novel alleles should be best verified by subcloning or other adequate methodologies. For prediction of the acetylator phenotype it seems generally sufficient to genotype NAT2 mutations C282T and T341C. In African populations, however, it is necessary to check additionally for the frequent G191A mutation, which codes also for a slow acetylator variant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208651     DOI: 10.1097/00008571-199902000-00016

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  17 in total

Review 1.  Development of analytical technology in pharmacogenetic research.

Authors:  Ann K Daly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

2.  Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

Authors:  Gabriele Stocco; Eva Cuzzoni; Sara De Iudicibus; Diego Favretto; Noelia Malusà; Stefano Martelossi; Elena Pozzi; Paolo Lionetti; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.

Authors:  Olayinka A Kotila; Olufunmilayo I Fawole; Olufunmilayo I Olopade; Adejumoke I Ayede; Adeyinka G Falusi; Chinedum P Babalola
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

4.  N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer.

Authors:  Steffen Pistorius; Heike Goergens; Christoph Engel; Jens Plaschke; Stefan Krueger; Ruth Hoehl; Hans-Detlev Saeger; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2006-08-02       Impact factor: 2.571

5.  CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Authors:  Nicolas Vuilleumier; Michel F Rossier; Alberto Chiappe; Florence Degoumois; Pierre Dayer; Bernadette Mermillod; Laurent Nicod; Jules Desmeules; Denis Hochstrasser
Journal:  Eur J Clin Pharmacol       Date:  2006-04-27       Impact factor: 2.953

6.  A simple, bead-based approach for multi-SNP molecular haplotyping.

Authors:  James D Hurley; Linda J Engle; Jesse T Davis; Adam M Welsh; John E Landers
Journal:  Nucleic Acids Res       Date:  2005-01-06       Impact factor: 16.971

7.  Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.

Authors:  Gustavo N O Costa; Luiz A V Magno; Cinthia V N Santana; Cibele Konstantinovas; Samuel T Saito; Moara Machado; Giuliano Di Pietro; Luciana Bastos-Rodrigues; Débora M Miranda; Luiz A De Marco; Marco A Romano-Silva; Fabrício Rios-Santos
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

Review 8.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 9.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

10.  Arylamine N-acetyltransferase-2 genotypes in the Thai population.

Authors:  Veerapol Kukongviriyapan; Auemduan Prawan; Wichittra Tassaneyakul; Jareerat Aiemsa-Ard; Benjamart Warasiha
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.